Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent

Cancer

Volumn 118, Issue 22, 2012, Pages 5644-5651

  Salloum, Ramzi G ^a,b   Hornbrook, Mark C ^c   Fishman, Paul A ^d   Ritzwoller, Debra P ^e   O'Keeffe Rossetti, Maureen C ^c   Elston Lafata, Jennifer ^b,f  

^a IL   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

^e Kaiser Permanente Colorado   (United States)

^f VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

breast cancer; cancer survivors; colorectal cancer; guideline concordance

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; BARIUM ENEMA; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVOR; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED PRACTICE; FEMALE; HOUSEHOLD; HUMAN; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SIGMOIDOSCOPY; SOCIAL STATUS; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; BREAST NEOPLASMS; COHORT STUDIES; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM METASTASIS; OFFICE VISITS; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PHYSICIAN'S PRACTICE PATTERNS; POPULATION SURVEILLANCE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SURVIVORS;

EID: 84868190926     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27544     Document Type: Article

References (33)

1. Institute of Medicine. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: National Academy Press; 2006.
2. National Comprehensive Cancer Network. Breast Cancer. Practice Guidelines in Oncology. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed March 8, 2011.
3. National Comprehensive Cancer Network. Colon Cancer. Practice Guidelines in Oncology. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed March 8, 2011.
4. Desch CE, Benson AB 3rd, Smith TJ, et al. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol. 1999; 17: 1312.
5. Smith TJ, Davidson NE, Schapira DV, et al. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol. 1999; 17: 1080-1082.
6. Rex DK, Kahi CJ, Levin B, et al. American Cancer Society; US Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2006; 130: 1865-1871.
7. The University of Texas MD Anderson Cancer Center. Clinical and Scientific Resources. Guidelines by Disease Site. http://www.mdanderson.org/ education-and-research/resources-for-professionals/index.html. Updated 2011. Accessed March 8, 2011.
8. Grunfeld E, Dhesy-Thind S, Levine M,; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ. 2005; 172: 1319-1320.
9. Winawer S, Fletcher R, Rex D, et al. Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. 2003; 124: 544-560.
10. Lash TL, Silliman RA,. Medical surveillance after breast cancer diagnosis. Med Care. 2001; 39: 945-955.
11. Elston Lafata J, Cole Johnson C, Ben-Menachem T, Morlock RJ,. Sociodemographic differences in the receipt of colorectal cancer surveillance care following treatment with curative intent. Med Care. 2001; 39: 361-372.
12. Cooper GS, Johnson CC, Lamerato L, et al. Use of guideline recommended follow-up care in cancer survivors: routine or diagnostic indications? Med Care. 2006; 44: 590-594.
13. Cooper GS, Schultz L, Simpkins J, Lafata JE,. The utility of administrative data for measuring adherence to cancer surveillance care guidelines. Med Care. 2007; 45: 66-72.
14. Elston Lafata J, Simpkins J, Schultz L, et al. Routine surveillance care after cancer treatment with curative intent. Med Care. 2005; 43: 592-599.
15. Rolnick S, Hensley Alford S, Kucera GP, et al. Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer. J Natl Cancer Inst Monogr. 2005;(35): 96-101.
16. Rulyak SJ, Mandelson MT, Brentnall TA, Rutter CM, Wagner EH,. Clinical and sociodemographic factors associated with colon surveillance among patients with a history of colorectal cancer. Gastrointest Endosc. 2004; 59: 239-247.
17. Cooper GS, Koroukian SM,. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2004; 100: 418-424.
18. Cooper GS, Kou TD, Reynolds HL Jr,. Receipt of guideline-recommended follow-up in older colorectal cancer survivors: a population-based analysis. Cancer. 2008; 113: 2029-2037.
19. Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC,. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004; 22: 315-321.
20. Ellison GL, Warren JL, Knopf KB, Brown ML,. Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery. Health Serv Res. 2003; 38 (6 pt 2): 1885-1903.
21. Schapira MM, McAuliffe TL, Nattinger AB,. Underutilization of mammography in older breast cancer survivors. Med Care. 2000; 38: 281-289.
22. Lamont EB, Herndon JE 2nd, Weeks JC, et al. Cancer and Leukemia Group B. Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst. 2006; 98: 1335-1338.
23. Deyo RA, Cherkin DC, Ciol MA,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45: 613-619.
24. Geller BM, Kerlikowske K, Carney PA, et al. Mammography surveillance following breast cancer. Breast Cancer Res Treat. 2003; 81: 107-115.
25. Ko CW, Kreuter W, Baldwin LM,. Effect of Medicare coverage on use of invasive colorectal cancer screening tests. Arch Intern Med. 2002; 162: 2581-2586.
26. Stiggelbout AM, de Haes JC, Vree R, et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer. 1997; 75: 914-920.
27. Kjeldsen BJ, Thorsen H, Whalley D, Kronborg O,. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol. 1999; 34: 509-515.
28. Kiebert GM, Welvaart K, Kievit J,. Psychological effects of routine follow up on cancer patients after surgery. Eur J Surg. 1993; 159: 601-607.
29. Papagrigoriadis S, Heyman B,. Patients' views on follow up of colorectal cancer: implications for risk communication and decision making. Postgrad Med J. 2003; 79: 403-407.
30. Hewitt ME, Bamundo A, Day R, Harvey C,. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol. 2007; 25: 2270-2273.
31. Partridge AH, Winer EP, Burstein HJ,. Follow-up care of breast cancer survivors. Semin Oncol. 2003; 30: 817-825.
32. Kantsiper M, McDonald EL, Geller G, Shockney L, Snyder C, Wolff AC,. Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med. 2009; 24 (suppl 2): S459-S466.
33. National Committee for Quality Assurance. NCQA Health Plan Report Card. http://reportcard.ncqa.org/plan/external/plansearch.aspx. Accessed October 1, 2011.